Dong Wei

Dong Wei

Company: EdiGene

Job title: Chief Executive Officer


RNA Therapeutics with LEAPER 2.0: Initial Proof of Concept in Preclinical Models including Human Primary Cells, Mice and Nonhuman Primates 9:10 am

Understanding how therapeutically meaningful RNA editing rate was achieved in human primary cells in selected genetic diseases Comparing to LEAPER 1.0, LEAPER 2.0 results in a significantly higher level of RNA editing in a mouse model Highlighting the potent and durable RNA editing achieved in multiple target organs of non-human primates via AAV delivery of…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.